Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

Novo Nordisk (NYSE: NVO) has seen revenue soar in recent years thanks to two drugs that have helped people around the world ...

Dublin, April 17, 2025 (GLOBE NEWSWIRE) -- The "Pen Needles Market by Type (Standard ... Prominent players include Embecta Corp. (US), Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), B.

Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular ... such as those who are afraid of needles, could soon access treatment in a more convenient way. " ...

Danish drugmaker Novo Nordisk said several hundred counterfeit units of its diabetes drug Ozempic were being distributed in ...

Novo Nordisk A/S ... The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin ...

Key market players include Embecta Corp., Novo Nordisk, and Ypsomed ... with an increased demand for insulin delivery devices, particularly pen needles, due to their ease of use and minimized ...

Growth is driven by the rising prevalence of diabetes among the elderly, necessitating efficient insulin delivery solutions ...